We aim to explore the implementation and delivery process of interprofessional education focused on medication safety catered students of nursing, pharmacy and medicine across three European countries.
To determine the need for repeated booster vaccinations in healthy individuals and to aid policymakers in future public health interventions for COVID-19. Gain insight into the immunogenicity of the additional bivalent booster vaccination in a representative sample of the healthy Dutch population. We aim to investigate three main topics:
i) immunogenicity of bivalent vaccines after priming with adenovirus- or mRNA-based vaccines,
ii) immunological recall responses and reactivity with relevant variants after booster vaccination, and
iii) the necessity of booster vaccinations for the healthy population in the future.
All people living with HIV need life-long treatment with antiretroviral therapy (ART). However, ART coverage in children living with HIV continues to lag behind adults and many paediatric patients in sub-Saharan Africa still do not receive optimal paediatric treatment formulations or state-of-the-art drugs. Studies of efficacy and safety of these drugs in children have lagged behind, and the full range of appropriate formulations to treat younger children are yet to be developed for both first- and second-line treatments.
Het optimaliseren van de antivirale behandeling van kinderen met HIV in Afrika door verdieping in de PK/PD van deze middelen, nieuwe formuleringen en het voorspellen van de PK middels modelleren.